Healthy Clinical Trial
Official title:
Ipsilateral Transfer of Motor Skill From Upper to Lower Limb in Healthy Adults: a Randomized Controlled Trial
To determine whether there is an ipsilateral transfer of a motor skill from the upper limb to the lower limb
In a single-blind randomized controlled study, 60 healthy subjects randomly participated in one of three single-session interventions: (1) Practicing reaching movement (RM) sequences with the non-dominant left upper limb towards illuminating switches (UL group); (2) Observing the identical sequences of the illuminating switches (Switches Observation (SO) group); and (3) Observing nature movies (Nature Observation (NO) group). Subjects participated in two sessions. The first session included familiarization practice of the motor task, a pretest, a single session intervention (according to group randomization), and a posttest. The second session included a retest, 24 hours after the training. Recording apparatus used in tests (pretest, posttest, and retest): A custom-made testing device was set up on a rectangular table with a smooth laminated tabletop of 105 cm × 80 cm and adjustable height. Five switch-led units of 5 cm × 8 cm × 5 cm, each composed of a large push-button switch and a red light-emitting diode (LED), attached to the tabletop in a 38-cm radius half circle, successively numbered from 1 to 5. The system was operated by a desktop computer, interfaced with a data acquisition card of LABVIEW software. The algorithm allowed parameters selection of LED activation (illumination) sequence, duration of RM, the delay between RMs, and the number of RM repetitions. Activation of a specific unit LED was a cue for the subject to reach toward that unit and press the push-button switch. Reaching toward the switch of an activated unit deactivated it, and the response time, between the activated and deactivated LED, was recorded. For testing the leg performance, subjects sat on a custom-designed plinth with a solid back support in front of the apparatus at the same height as the tabletop, hence they could perform the RM sequence with the leg. At the starting position, the heel was placed on the edge of the table in front of switch 3, so when the left heel touched switch 3, the knee reached 30° flexion. Training conditions: In each of the UL, SO, and NO groups, a 16-minute single-session intervention was conducted. The initial testing position of the subjects during the intervention was sitting on a chair with solid back support, hips, and knees flexed 90°, in front of the apparatus used for the tests. The starting position of the UL group was placing the left fist on the edge of the table in front of the subject's chest (parallel to switch 3) so that they could reach and touch switch 3 with their third left metacarpal. The UL group was instructed to reach with the left UL from the starting position as fast and accurately as possible to the illuminating switch, press it, and return to the starting position, while the fist must remain in contact with the table. They were not notified about the sequence. The subjects performed RMs toward the units that were activated in the same order as the tested sequence 1-4-3-5-4-2, and with an activation duration and delay of 1 s. The practice included 16 blocks, each consisting of 30 RM with a 30 s pause after each block (Fig. 1b). The SO group was instructed to observe the illuminating switches while avoiding moving. The subjects observed RMs toward the units that were activated in the same order as the practiced sequence 1-4-3-5-4-2, also with an activation duration and delay of 1 s and 30 s pause after each block. The NO group was instructed to observe a video clip while avoiding moving. The video clip consisted of a 16 min nature movie in cycles of one-minute observation and pausing 30 s, equivalent to the timing of RMs performed by groups UL and SO. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |